within Pharmacolibrary.Drugs.ATC.A;

model A06AD04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 7.133333333333334e-05,
    adminDuration  = 600,
    adminMass      = 4000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.01326,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.02091,
    k12             = 5.74,
    k21             = 5.74
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A06AD04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Magnesium sulfate is an inorganic salt used in medicine for a variety of indications. It is primarily used intravenously for the prevention and treatment of seizures in pre-eclampsia and eclampsia, as well as in the management of hypomagnesemia and torsades de pointes. It is also administered orally as a laxative. Magnesium sulfate is an approved and widely used medication in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for adult pregnant women with pre-eclampsia, following intravenous administration. Population pharmacokinetic study.</p><h4>References</h4><ol><li><p>Lu, JF, &amp; Nightingale, CH (2000). Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. <i>Clinical pharmacokinetics</i> 38(4) 305–314. DOI:<a href=\"https://doi.org/10.2165/00003088-200038040-00002\">10.2165/00003088-200038040-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10803454/\">https://pubmed.ncbi.nlm.nih.gov/10803454</a></p></li><li><p>Rower, JE, et al., &amp; Finkelstein, Y (2025). Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations. <i>Journal of clinical pharmacology</i> 65(6) 665–674. DOI:<a href=\"https://doi.org/10.1002/jcph.6179\">10.1002/jcph.6179</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39775569/\">https://pubmed.ncbi.nlm.nih.gov/39775569</a></p></li><li><p>Brookfield, K, et al., &amp; Carvalho, B (2021). Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia. <i>AJOG global reports</i> 1(4) 100018–None. DOI:<a href=\"https://doi.org/10.1016/j.xagr.2021.100018\">10.1016/j.xagr.2021.100018</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36277458/\">https://pubmed.ncbi.nlm.nih.gov/36277458</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A06AD04;
